vs

Side-by-side financial comparison of COMPUGEN LTD (CGEN) and Origin Materials, Inc. (ORGN). Click either name above to swap in a different company.

COMPUGEN LTD is the larger business by last-quarter revenue ($3.5M vs $3.0M, roughly 1.2× Origin Materials, Inc.). COMPUGEN LTD runs the higher net margin — -410.1% vs -6423.8%, a 6013.7% gap on every dollar of revenue. On growth, COMPUGEN LTD posted the faster year-over-year revenue change (-61.8% vs -67.2%). Origin Materials, Inc. produced more free cash flow last quarter ($-18.0M vs $-18.8M).

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

Origin Systems, Inc. was an American video game developer based in Austin, Texas. It was founded on March 3, 1983, by Richard Garriott and his brother Robert. Origin is best known for their groundbreaking work in multiple genres of video games, such as the Ultima and Wing Commander series. The company was purchased by Electronic Arts in 1992.

CGEN vs ORGN — Head-to-Head

Bigger by revenue
CGEN
CGEN
1.2× larger
CGEN
$3.5M
$3.0M
ORGN
Growing faster (revenue YoY)
CGEN
CGEN
+5.5% gap
CGEN
-61.8%
-67.2%
ORGN
Higher net margin
CGEN
CGEN
6013.7% more per $
CGEN
-410.1%
-6423.8%
ORGN
More free cash flow
ORGN
ORGN
$764.0K more FCF
ORGN
$-18.0M
$-18.8M
CGEN

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CGEN
CGEN
ORGN
ORGN
Revenue
$3.5M
$3.0M
Net Profit
$-14.5M
$-194.1M
Gross Margin
Operating Margin
-475.1%
-6438.5%
Net Margin
-410.1%
-6423.8%
Revenue YoY
-61.8%
-67.2%
Net Profit YoY
-54.7%
-1335.6%
EPS (diluted)
$-0.16
$-50.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGEN
CGEN
ORGN
ORGN
Q4 25
$3.0M
Q3 25
$4.7M
Q2 25
$3.5M
$5.8M
Q1 25
$5.4M
Q4 24
$9.2M
Q3 24
$8.2M
Q2 24
$9.3M
$7.0M
Q1 24
$2.6M
$6.8M
Net Profit
CGEN
CGEN
ORGN
ORGN
Q4 25
$-194.1M
Q3 25
$-16.4M
Q2 25
$-14.5M
$-12.7M
Q1 25
$-26.4M
Q4 24
$-13.5M
Q3 24
$-36.8M
Q2 24
$-9.4M
$-19.5M
Q1 24
$7.3M
$-13.9M
Gross Margin
CGEN
CGEN
ORGN
ORGN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
60.5%
Q1 24
17.9%
Operating Margin
CGEN
CGEN
ORGN
ORGN
Q4 25
-6438.5%
Q3 25
-363.6%
Q2 25
-475.1%
-257.5%
Q1 25
-600.8%
Q4 24
-175.7%
Q3 24
-395.1%
Q2 24
-128.5%
-259.6%
Q1 24
-263.7%
Net Margin
CGEN
CGEN
ORGN
ORGN
Q4 25
-6423.8%
Q3 25
-351.8%
Q2 25
-410.1%
-219.3%
Q1 25
-486.9%
Q4 24
-146.6%
Q3 24
-448.2%
Q2 24
-101.4%
-277.3%
Q1 24
284.0%
-203.9%
EPS (diluted)
CGEN
CGEN
ORGN
ORGN
Q4 25
$-50.17
Q3 25
$-0.11
Q2 25
$-0.16
$-0.09
Q1 25
$-0.18
Q4 24
$-17.04
Q3 24
$-0.26
Q2 24
$-0.10
$-0.14
Q1 24
$89505618.00
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGEN
CGEN
ORGN
ORGN
Cash + ST InvestmentsLiquidity on hand
$35.3M
$32.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$50.3M
$104.2M
Total Assets
$106.5M
$157.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGEN
CGEN
ORGN
ORGN
Q4 25
$32.9M
Q3 25
$34.1M
Q2 25
$35.3M
$35.3M
Q1 25
$43.8M
Q4 24
$56.3M
Q3 24
$56.4M
Q2 24
$44.6M
$55.7M
Q1 24
$39.3M
$75.8M
Stockholders' Equity
CGEN
CGEN
ORGN
ORGN
Q4 25
$104.2M
Q3 25
$295.0M
Q2 25
$50.3M
$311.1M
Q1 25
$314.6M
Q4 24
$338.4M
Q3 24
$358.9M
Q2 24
$58.3M
$390.6M
Q1 24
$65.6M
$408.2M
Total Assets
CGEN
CGEN
ORGN
ORGN
Q4 25
$157.7M
Q3 25
$327.3M
Q2 25
$106.5M
$348.4M
Q1 25
$349.0M
Q4 24
$378.0M
Q3 24
$399.6M
Q2 24
$110.2M
$431.0M
Q1 24
$121.3M
$448.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGEN
CGEN
ORGN
ORGN
Operating Cash FlowLast quarter
$-18.6M
$-8.9M
Free Cash FlowOCF − Capex
$-18.8M
$-18.0M
FCF MarginFCF / Revenue
-530.8%
-596.6%
Capex IntensityCapex / Revenue
6.5%
301.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-63.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGEN
CGEN
ORGN
ORGN
Q4 25
$-8.9M
Q3 25
$-8.1M
Q2 25
$-18.6M
$-7.3M
Q1 25
$-8.4M
Q4 24
$-5.7M
Q3 24
$-13.4M
Q2 24
$39.7M
$-15.0M
Q1 24
$-16.7M
Free Cash Flow
CGEN
CGEN
ORGN
ORGN
Q4 25
$-18.0M
Q3 25
$-13.5M
Q2 25
$-18.8M
$-16.0M
Q1 25
$-15.4M
Q4 24
$-9.5M
Q3 24
$-16.0M
Q2 24
$39.7M
$-15.6M
Q1 24
$-18.7M
FCF Margin
CGEN
CGEN
ORGN
ORGN
Q4 25
-596.6%
Q3 25
-290.5%
Q2 25
-530.8%
-275.4%
Q1 25
-284.2%
Q4 24
-103.5%
Q3 24
-194.7%
Q2 24
428.3%
-221.8%
Q1 24
-273.6%
Capex Intensity
CGEN
CGEN
ORGN
ORGN
Q4 25
301.4%
Q3 25
115.7%
Q2 25
6.5%
149.9%
Q1 25
128.8%
Q4 24
41.6%
Q3 24
31.0%
Q2 24
0.4%
9.0%
Q1 24
28.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons